Results 81 to 90 of about 8,552 (153)
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by ectopic fibroblast growth factor-23 (FGF23) production. We report a unique case of a 78-year-old female patient with refractory hypophosphatemia, ultimately diagnosed as ...
Marcello Moro Queiroz, MD +13 more
doaj +1 more source
Left ventricular hypertrophy (LVH) is associated with increased cardiac expression of fibroblast growth factor-23 (FGF23) in mice and men. To further elucidate the role of cardiac FGF23 in LVH, we specifically ablated Fgf23 in cardiomyocytes, and ...
Nejla Latic +13 more
doaj +1 more source
FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation
Background High level of serum fibroblast growth factor 23 (FGF23) is implicated in the development and progression of diabetic nephropathy (DN), making it a crucial factor in the pathogenesis of DN.
Xiaomin Zhang +5 more
doaj +1 more source
Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm in which the tumor cells produce fibroblast growth factor 23 (FGF23), leading to oncogenic osteomalacia and thus a distinct clinical presentation.
Aidan Kerr +5 more
doaj +1 more source
Studies on the regulation of the phosphaturic hormone fibroblast growth factor 23 (FGF23)
Fibroblasten-Wachstumsfaktor 23 (FGF23) ist ein aus dem Knochen stammendes Hormon, das den Blutspiegel von Phosphat und aktivem Vitamin D reguliert. Bei diversen menschlichen Erkrankungen, wie Nieren- oder Herz-Kreislauf-Erkrankungen, ist der FGF23-Spiegel verändert, wodurch es auch seine klinische Relevanz erlangt.
openaire +2 more sources
Summary: With exercise, muscle and bone produce factors with beneficial effects on brain, fat, and other organs. Exercise in mice increased fibroblast growth factor 23 (FGF23), urine phosphate, and the muscle metabolite L-β-aminoisobutyric acid (L-BAIBA),
Eijiro Sakamoto +9 more
doaj +1 more source
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia. [PDF]
Hartley IR +11 more
europepmc +1 more source
Research progress on the biological role of serum soluble α-Klotho in chronic kidney diseases
α-Klotho is an anti-aging protein, which has been reported to bind with fibroblast growth factor receptor-1(FGFR1) to become a transmembrane co-receptor of fibroblastic growth factor-23(FGF23), thereby mediating FGF23/FGFR1/Klotho signaling to play a key
SUN Long +5 more
doaj
Summary: One of the main regulators of phosphate homeostasis is fibroblast growth factor 23 (FGF23), secreted by osteocytes. The effects of organic versus inorganic dietary phosphate on this homeostasis are unclear.
Danielle M.A. Ratsma +5 more
doaj +1 more source

